Found: 325
Select item for more details and to access through your institution.
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
- Published in:
- Metabolic Syndrome & Related Disorders, 2018, v. 16, n. 10, p. 530, doi. 10.1089/met.2018.0066
- By:
- Publication type:
- Article
The Gut-Bone Axis in Diabetes.
- Published in:
- Current Osteoporosis Reports, 2023, v. 21, n. 1, p. 21, doi. 10.1007/s11914-022-00767-2
- By:
- Publication type:
- Article
O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S198, doi. 10.1093/schbul/sbz021.268
- By:
- Publication type:
- Article
Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. e259, doi. 10.1210/clinem/dgad431
- By:
- Publication type:
- Article
Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. e1597, doi. 10.1210/clinem/dgad372
- By:
- Publication type:
- Article
Expression of Neurotensin and Its Receptors Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 9, p. 2211, doi. 10.1210/clinem/dgad146
- By:
- Publication type:
- Article
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring".
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 10, p. e4307, doi. 10.1210/clinem/dgab221
- By:
- Publication type:
- Article
Expression of Cholecystokinin and its Receptors in the Intestinal Tract of Type 2 Diabetes Patients and Healthy Controls.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. e966, doi. 10.1210/clinem/dgaa803
- By:
- Publication type:
- Article
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
- Published in:
- 2021
- By:
- Publication type:
- journal article
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4092, doi. 10.3390/ijms20174092
- By:
- Publication type:
- Article
Glucagon Receptor Signaling and Glucagon Resistance.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 13, p. 3314, doi. 10.3390/ijms20133314
- By:
- Publication type:
- Article
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 10, p. 1927, doi. 10.1093/ndt/gfab266
- By:
- Publication type:
- Article
MLJ reviews.
- Published in:
- 1994
- By:
- Publication type:
- Book Review
The Language Teacher (Book).
- Published in:
- 1989
- By:
- Publication type:
- Book Review
The Functional-National Approach From Theory to Practice (Book).
- Published in:
- 1984
- By:
- Publication type:
- Book Review
Communicative Syllabus Design and Methodology (Book).
- Published in:
- 1983
- By:
- Publication type:
- Book Review
Action for the '80s (Book).
- Published in:
- 1982
- By:
- Publication type:
- Book Review
A Time-Based Approach to the Study of Teacher Effectiveness.
- Published in:
- Modern Language Journal, 1982, v. 66, n. 3, p. 243, doi. 10.1111/j.1540-4781.1982.tb06984.x
- By:
- Publication type:
- Article
Performing with Objectives (Book).
- Published in:
- 1975
- By:
- Publication type:
- Book Review
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3213, doi. 10.3390/jcm9103213
- By:
- Publication type:
- Article
Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 965, doi. 10.1111/j.1463-1326.2011.01427.x
- By:
- Publication type:
- Article
Regulation of glucagon secretion by incretins.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, p. 89, doi. 10.1111/j.1463-1326.2011.01452.x
- By:
- Publication type:
- Article
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 4, p. 323, doi. 10.1111/j.1463-1326.2009.01167.x
- By:
- Publication type:
- Article
Letter: Bif195 for aspirin‐induced gastric mucosal damage – More to do in further research. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1306, doi. 10.1111/apt.18002
- By:
- Publication type:
- Article
Editorial: The microbiome and gastric mucosal protection in aspirin users—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Featured Cover.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 3, p. i, doi. 10.1111/apt.17884
- By:
- Publication type:
- Article
Bifidobacterium breve Bif195 ameliorates aspirin‐induced gastric mucosal damage: A randomised, double blind, placebo‐controlled crossover trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 3, p. 341, doi. 10.1111/apt.17817
- By:
- Publication type:
- Article
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2010, v. 3, p. 155
- By:
- Publication type:
- Article
The Authors Reply:.
- Published in:
- Kidney International, 2014, v. 85, n. 1, p. 212, doi. 10.1038/ki.2013.410
- By:
- Publication type:
- Article
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
- Published in:
- Kidney International, 2013, v. 83, n. 5, p. 915, doi. 10.1038/ki.2012.460
- By:
- Publication type:
- Article
Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2017, p. 4153, doi. 10.1210/jc.2017-01091
- By:
- Publication type:
- Article
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Response to the Letter: "Epidemiologic Association Between Antibiotic Use With the Risk of Developing Type 2 Diabetes" by López-Hernández, D.
- Published in:
- 2015
- By:
- Publication type:
- commentary
Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Elimination and Degradation of Glucagon-like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Patients with End-Stage Renal Disease.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 9, p. E1409, doi. 10.1210/jc.2011-0647
- By:
- Publication type:
- Article
Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 3, p. 737, doi. 10.1210/jc.2010-2435
- By:
- Publication type:
- Article
Increased Postprandial GIP and Glucagon Responses, But Unaltered GLP-1 Response after Intervention with Steroid Hormone, Relative Physical Inactivity, And High-Calorie Diet in Healthy Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. 447, doi. 10.1210/jc.2010-1605
- By:
- Publication type:
- Article
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1602, doi. 10.1007/s00125-024-06160-1
- By:
- Publication type:
- Article